Watson Pharmaceuticals (WPI) Q2 2012 Earnings Call July 26, 2012 8:30 am ET Executives Lisa M. Defrancesco - Former Vice President of Global Investor Relations Paul M. Bisaro - Chief Executive Officer, President and Director R. Todd Joyce - Chief Financial Officer -Global George Frederick Wilkinson - President of Global Brands and Biosimilars Sigurdur Oli Olafsson - President of Global Generics Analysts Gregory B. Gilbert - BofA Merrill Lynch, Research Division David Amsellem - Piper Jaffray Companies, Research Division Marc Goodman - UBS Investment Bank, Research Division David G. Buck - The Buckingham Research Group Incorporated Timothy Chiang - CRT Capital Group LLC, Research Division Christopher Schott - JP Morgan Chase & Co, Research Division Jami Rubin - Goldman Sachs Group Inc., Research Division Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division Elliot Wilbur - Needham & Company, LLC, Research Division Michael Faerm - Crédit Suisse AG, Research Division Ken Cacciatore - Cowen and Company, LLC, Research Division Gary Nachman - Susquehanna Financial Group, LLLP, Research Division Michael Kallai Tong - Wells Fargo Securities, LLC, Research Division David Risinger - Morgan Stanley, Research Division Randall Stanicky - Canaccord Genuity, Research Division Douglas D. Tsao - Barclays Capital, Research Division Shibani Malhotra - RBC Capital Markets, LLC, Research Division PresentationOperator
Good morning. My name is Cassandra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Watson second quarter earnings call. [Operator Instructions] And now, I would like to turn the call over to Lisa DeFrancesco, Vice President of Global Investor Relations.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Tuesday with 2.2 million shares changing hands. It is currently at two times its average daily volume and trading up $3.01 (+2.4%).
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Monday as it is currently trading at $127.42, above its previous 52-week high of $126.53 with 1.3 million shares traded as of 9:35 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Tuesday with 2.8 million shares changing hands. It is currently at 2.7 times its average daily volume and trading up $2.55 (+2.1%).